Dr. Richard Furie Discusses Lupus And Phase 3 BLISS-LN Clinical Trial | Podcast E42 Trialsitenews's podcast

Artwork

Fitness News TrialSite News On Covid19

Innehåll tillhandahållet av TrialSite News. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av TrialSite News eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.

trialsitenews's podcast « »
Dr. Richard Furie Discusses Lupus and Phase 3 BLISS-LN Clinical Trial | Podcast E42

4y ago 13:09

Dela

MP3•Episod hem

Innehåll tillhandahållet av TrialSite News. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av TrialSite News eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.

Dr. Richard Furie discuss his recent involvement with the Phase 3 BLISS-LN clinical trial that is setting the stage for the first ever FDA approved drug for lupus nephritis. Dr. Furie is a professor at the Feinstein Institutes for medical research, Northwell Health’s science arm of the health system. Regarded as one the senior rheumatologists in the New York metropolitan area, he has been on the Boards of Directors of the local chapters of the Arthritis Foundation and the Lupus Alliance of America and has been a member of the Medical-Scientific Advisory Council of the Lupus Foundation of America as well as its Lupus News editorial board. He also is on the Medical and Scientific Advisory Board of the SLE Foundation as well as the Alliance for Lupus Research Scientific Advisory Board.

… continue reading

82 episoder

#Fitness #News #TrialSite News #On Covid19

Artwork

Dr. Richard Furie Discusses Lupus and Phase 3 BLISS-LN Clinical Trial | Podcast E42

trialsitenews's podcast

published 4y ago

Dela

MP3•Episod hem

Innehåll tillhandahållet av TrialSite News. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av TrialSite News eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.

Dr. Richard Furie discuss his recent involvement with the Phase 3 BLISS-LN clinical trial that is setting the stage for the first ever FDA approved drug for lupus nephritis. Dr. Furie is a professor at the Feinstein Institutes for medical research, Northwell Health’s science arm of the health system. Regarded as one the senior rheumatologists in the New York metropolitan area, he has been on the Boards of Directors of the local chapters of the Arthritis Foundation and the Lupus Alliance of America and has been a member of the Medical-Scientific Advisory Council of the Lupus Foundation of America as well as its Lupus News editorial board. He also is on the Medical and Scientific Advisory Board of the SLE Foundation as well as the Alliance for Lupus Research Scientific Advisory Board.

… continue reading

82 episoder

#Fitness #News #TrialSite News #On Covid19

Alla avsnitt

×

Välkommen till Player FM

Player FM scannar webben för högkvalitativa podcasts för dig att njuta av nu direkt. Den är den bästa podcast-appen och den fungerar med Android, Iphone och webben. Bli medlem för att synka prenumerationer mellan enheter.

Lyssna på 500+ ämnen